Trials

Cross tumoral phase II clinical trial exploring crizotinib (PF-02341066) in patients with advanced tumors induced by causal alterations of ALK and/or MET

Cancer type: Lymphoma, Sarcoma

Phase: II

Principal Investigator: Aamdal Steinar

Country: NO

Keywords: Norway, Oslo, Sarcoma, Lymfoma, Crizotinib, EORTC, CREATE

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01524926?term=CREATE&rank=1